Variant & Polymorphism
repeat
| UGT1A1*28 genotype and male gender predict an increased incidence of liver functional test abnormalities during pegvisomant therapy in acromegaly |
|
patients carrying UGT1A1 *28 allele(s) are at an increased risk of irinotecan-induced severe diarrhoea |
|
UGT1A1*1 polymorphism, which results in lower serum levels of the endogenous antioxidant bilirubin, was associated with an increased risk of head and neck cancer |
|
UGT1A1 A(TA)(7)TAA allele is a potential risk factor for breast cancer in Caucasians |
|
the c.-3279T>G mutation in the UGT1A1 promoter is a genetic risk factor for neonatal jaundice |
|
rs6742078 variant explains 18percent of the variation in total of serum bilirubin levels |
|
|